On May 2, 2022, UAEM sent a letter to Ron Klain, White House Chief of Staff. The letter requests assurance that White House officials with financial conflicts of interest recuse themselves from the review of the petition asking the government to march-in and exercise other rights to the life-saving prostate cancer drug Xtandi (enzalutamide) originally developed with funds from the National Institutes of Health (NIH) and Department of Defense (DOD) at the University of California, Los Angeles (UCLA). Read the full text here.
UAEM has sent an open letter to The Hon. Robert M. Califf, the newly appointed U.S. Food and Drug Administration (FDA) Commissioner calling his leadership to attend with real urgency to the significant but so far underserved issue of clinical trial registration and results reporting.
Read the full letter here.
Due to sustained UAEM student organizing the University of California, Los Angeles (UCLA) has at last published the "Affordable Access Plan (AAP)"! The AAP provision is intended to better address the needs of underserved populations so that going forward medicines developed on the UCLA campus are not priced out of reach in low- and middle-income countries.
Latin American student members of UAEM call on their governments to reject the TRIPS waiver compromise.Read more
Dear UAEM Family & Friends,
It is with a very heavy heart that we write to share the devastating loss to our community with the sudden passing of our Advisory Board Member, Dr Paul Farmer, a world-renowned infectious disease doctor, founder of Partners in Health, humanitarian, author, father and friend.
Paul’s legacy is so far-reaching that it would be impossible to summarize his extraordinary impact here and so instead we choose to focus on how deeply he inspired and shaped the work of so many of us at UAEM; many of us learned about his early legacy in Haiti and around the world and, as students, had our own hopes and dreams of perhaps one day following in his footsteps.